Skip to main content
Log in

Glutathione synthetase deficiency: Is γ-glutamylcysteine accumulation a way to cope with oxidative stress in cells with insufficient levels of glutathione?

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Glutathione (GSH) plays a major role in the cellular defence against oxidative stress and other vital cellular functions. It therefore seems inevitable that patients with severe depletion of GSH will not survive. However, at least some with glutathione synthetase (GS) deficiency do. This study was done to determine whether these patients have a mechanism to compensate for their GSH deficiency. Cell-free extracts of cultured fibroblasts from 9 patients with GS deficiency and 9 control subjects were analysed by HPLC for low-molecular-weight thiol compounds. The patients′ cells contained 7.4 nmol of GSH per mg of protein (median; range 2.8–25.2) compared to 33.0 nmol in control fibroblasts (range 26.7–51.4) (p<0.01). On the other hand, the patients′ cells accumulated 18.1 nmol of γ-glutamylcysteine (γ-GC) per mg of protein (median; range 6.9–71.7), whereas the control cells contained 0.1 nmol (range 0.05–0.16) (p<0.01). The cysteine concentrations in the patients′ cells were 20.7 nmol/mg protein (median; range 9.4–52.9) compared to 8.9 nmol in control cells (range 3.0–12.4) (p<0.01). Cultured fibroblasts from patients with GS deficiency have low levels of GSH, but instead accumulate γ-GC. We suggest that γ-GC, which contains both reactive groups of GSH (i.e. the sulphydryl and γ-glutamyl groups), can compensate for GSH in the cellular defence against oxidative stress. Thus, γ-GC may alleviate, but only partly prevent, serious consequences of insufficient GSH levels in affected patients. Since the sum of the levels of GSH and γ-GC in GS-deficient cells (median 31.5 nmol/mg protein, range 16.2–79.0) was similar to the level of GSH alone incontrol cells (33.0 nmol/mg protein, range 26.7–51.4), we propose that the cultured fibroblasts may have a mechanism to regulate in a coordinated way the levels of GSH and γ-GC; for instance, by both compounds acting as feedback inhibitors of γ-GC synthetase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  • Dahl N, Pigg M, Ristoff E, et al (1997) Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, haemolytic anaemia and neurological dysfunction. Hum Mol Genet 6(7): 1147-1152.

    Google Scholar 

  • Janáky R, Varga V, Hermann A, Saransaari P, Oja SS (2000) Mechanisms of L-cysteine neurotoxicity. Neurochem Res 25(9-10): 1397-1405.

    Google Scholar 

  • Larsson A, Anderson M (2001) Glutathione synthetase deficiency and other disorders of the γ-glutamyl cycle. In Scriver CF, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw Hill, 2205-2216.

    Google Scholar 

  • Larsson A, Mattsson B, Hagenfeldt L, Moldéus P (1983) Glutathione synthetase-deficient human fibroblasts in culture. Clin Chim Acta 135: 57-64.

    Google Scholar 

  • Luo JL, Hammarqvist F, Cotgreave IA, Lind C, Andersson K, Wernerman J (1995) Determination of intracellular glutathione in human skeletal muscle by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Appl 670: 29-36.

    Google Scholar 

  • Richman PG, Meister A (1975) Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione. J Biol C hem 250: 1422-1426.

    Google Scholar 

  • Ristoff E, Larsson A (2002) Disorders of glutathione metabolism. In Rosenberg R, Prusiner S, DiMauroS, Barchi R, Nestler E, eds. The Molecular and Genetic Basis of Neurological Disease, 3rd ed, in press.

  • Ristoff E, Augustson C, Geissler J, et al (2000) A missense mutation in the heavy subunit of γ-glutamylcysteine synthetase gene causes hemolytic anemia. Blood 95: 2193-2196.

    Google Scholar 

  • Ristoff E, Mayatepek E, Larsson A (2001) Long-term clinical outcome in patients with glutathione synthetase deficiency. J Pediatr 139: 79-84.

    Google Scholar 

  • Shi ZZ, Osei Frimpong J, Kala G, et al (2000) Glutathione synthesis is essential for mouse development but not for cell growth in culture. Proc Natl Acad Sci USA 97: 5101-5106.

    Google Scholar 

  • Wellner VP, Sekura R, Meister A, Larsson A (1974) Glutathione synthetase deficiency, an inborn error of metabolism involving the gamma-glutamyl cycle in patients with 5-oxoprolinuria (pyroglutamic aciduria). Proc Natl Acad Sci USA 71: 2505-2509.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. Ristoff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ristoff, E., Hebert, C., Njålsson, R. et al. Glutathione synthetase deficiency: Is γ-glutamylcysteine accumulation a way to cope with oxidative stress in cells with insufficient levels of glutathione?. J Inherit Metab Dis 25, 577–584 (2002). https://doi.org/10.1023/A:1022095324407

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022095324407

Keywords

Navigation